Salvage cisplatin and adriamycin for advanced or recurrent basal or squamous cell carcinoma of the face.

Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma.

Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.

Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face.

$Intraperitoneal cisplatin in the treatment of refractory or recurrent advanced ovarian carcinoma.$
Intraperitoneal cisplatin in the treatment of refractory or recurrent advanced ovarian carcinoma.

[Comedo or basal cell carcinoma?].

Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer.

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.

Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone.

Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma.

Cisplatin-containing regimen in advanced or recurrent granulosa cell tumours of the ovary.

or Metastatic Squamous Cell Cancer of the Head and Neck.

Salvage Surgery for Patients With Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma Involving the Carotid Artery.

Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck.

Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva.

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma.

Irinotecan plus fluorouracil-based regimen as second or third-line chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma.

or metastatic squamous cell carcinoma of the head and neck in the Netherlands.

Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.

Salvage surgery for locoregional recurrences of advanced pharyngolaryngeal squamous cell carcinoma after organ preservation failure.

A retrospective study on combination therapy with ifosfamide, adriamycin and cisplatin for progressive or recurrent uterine sarcoma.

Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.

Systemic therapy for advanced basal cell carcinoma.

Radiotherapy or surgery for squamous cell oesophageal carcinoma?

Salvage surgery for head and neck squamous cell carcinoma.

Suggest Documents

Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma.

Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.

Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face.

Intraperitoneal cisplatin in the treatment of refractory or recurrent advanced ovarian carcinoma.

[Comedo or basal cell carcinoma?].

Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer.

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.

Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone.

Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma.

Cisplatin-containing regimen in advanced or recurrent granulosa cell tumours of the ovary.

or Metastatic Squamous Cell Cancer of the Head and Neck.

Salvage Surgery for Patients With Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma Involving the Carotid Artery.

Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck.

Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva.

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma.

Irinotecan plus fluorouracil-based regimen as second or third-line chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma.

or metastatic squamous cell carcinoma of the head and neck in the Netherlands.

Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.

Salvage surgery for locoregional recurrences of advanced pharyngolaryngeal squamous cell carcinoma after organ preservation failure.

A retrospective study on combination therapy with ifosfamide, adriamycin and cisplatin for progressive or recurrent uterine sarcoma.

Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.

Systemic therapy for advanced basal cell carcinoma.

Radiotherapy or surgery for squamous cell oesophageal carcinoma?

Salvage surgery for head and neck squamous cell carcinoma.

Salvage cisplatin and adriamycin for advanced or recurrent basal or squamous cell carcinoma of the face.

Recommend Documents

Follow Us